Powered by Guardant Infinity smart liquid biopsy platform, advanced multiomic test evaluates genomic, epigenomic and RNA-based molecular data First tissue comprehensive genomic profiling test to offer ...

--Landmark approval advances personalized cancer care as an estimated 1 in 3 patients across five common advanced cancers are expected to match with an FDA-approved therapy-- CAMBRIDGE, ...

Characterization of Non–Small-Cell Lung Cancers With MET Exon 14 Skipping Alterations Detected in Tissue or Liquid: Clinicogenomics and Real-World Treatment Patterns Among 31,165 (97.2%) samples where ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced today that it has received new commercial health plan coverage for the ...

Image-based profiling is a maturing strategy by which the rich information present in biological images is reduced to a multidimensional profile, a collection of extracted image-based features. These ...

Oncotarget published "Analytic validation and clinical utilization of the comprehensive genomic profiling test, GEM ExTra®" which reported that the authors developed and analytically validated a ...

Comprehensive genomic profiling (CGP) creates individual genomic profiles of tumors or tumor/normal tissues to explore therapeutic options. The primary objective of CGP testing is to guide patient ...

Singapore's leading national tertiary cancer centre, National Cancer Centre Singapore, has announced a new S$6 million ($4.7 million) collaboration to develop an AI-powered cancer test that uses ...

Please provide your email address to receive an email when new articles are posted on . A lipid profiling blood test may predict the risk for type 2 diabetes and CVD years in advance, according to ...

In this article, we will be taking a look at the 11 Best Performing Biotech Stocks So Far in 2025. Caris Life Sciences, Inc. stands tenth among them. Caris Life Sciences, Inc. (NASDAQ:CAI) is a ...